FDA Adverse Event Malfunction Summary report: N

FLEXTEND

MDR report key: 2162367 · Received July 14, 2011

Report

Report Number
2124215-2011-07270
Event Type
Malfunction
Date Received
July 14, 2011
Date of Event
April 19, 2011
Report Date
May 6, 2011
Manufacturer
CPI - DEL CARIBE
Product Code
NVN
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
SC
Reporter Occupation
MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE

Narratives

Additional Manufacturer Narrative · 1

THE LEAD HAS BEEN RETURNED. WHEN ANALYSIS IS COMPLETE, THIS REPORT WILL BE UPDATED.

Additional Manufacturer Narrative · 1

UPON RECEIPT AT OUR POST MARKET QUALITY ASSURANCE LABORATORY, VISUAL INSPECTION NOTED DAMAGE HAD OCCURRED TO THE LEAD BODY AND DRIED BLOOD AND BODILY FLUID HAD INFILTRATED THROUGH THE HELIX HOUSING AND UP THROUGH THE LEAD LUMEN. THE LEAD WAS THEN SUBJECT TO RESISTANCE AND PRESSURE TESTING WHICH VERIFIES THE LEAD'S ELECTRICAL PERFORMANCE AND INNER INSULATION INTEGRITY. MEASUREMENTS THROUGHOUT THESE TESTS WERE WITHIN NORMAL LIMITS. LABORATORY TECHNICIANS WERE UNABLE TO REPLICATE THE CLINICAL OBSERVATIONS IN THE FIELD AND THE DAMAGE FOUND TO THE LEAD DURING VISUAL TESTING WAS DETERMINED TO BE PROCEDURALLY INDUCED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT DURING A NORMAL GENERATOR REPLACEMENT PROCEDURE, IT WAS OBSERVED THAT THE ATRIAL LEAD HAD DISLODGED AND WAS FREE FLOATING IN THE ATRIUM. IT WAS NOTED THAT SINCE IMPLANT, ATRIAL THRESHOLD MEASUREMENTS WERE INTERMITTENT AND HIGH AND SENSING WAS POOR. THE PHYSICIAN ATTEMPTED TO REPOSITION THE LEAD, HOWEVER EXPERIENCED GETTING A NON-BOSTON SCIENTIFIC STYLET DOWN THE LEAD. THE LEAD WAS THEN SUCCESSFULLY EXPLANTED FROM THE PATIENT AND A NEW ATRIAL LEAD WAS IMPLANTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 FLEXTEND IMPLANTABLE LEAD NVN CPI - DEL CARIBE 4087

Patients

Seq Age Sex Outcome Treatment
1 62 YR S606| 4470| 4088| 1296| 4087